Chemoprevention of pancreatic cancer: ready for the clinic?
about
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancerDeploying mouse models of pancreatic cancer for chemoprevention studiesChemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway.
P2860
Chemoprevention of pancreatic cancer: ready for the clinic?
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chemoprevention of pancreatic cancer: ready for the clinic?
@ast
Chemoprevention of pancreatic cancer: ready for the clinic?
@en
Chemoprevention of pancreatic cancer: ready for the clinic?
@nl
type
label
Chemoprevention of pancreatic cancer: ready for the clinic?
@ast
Chemoprevention of pancreatic cancer: ready for the clinic?
@en
Chemoprevention of pancreatic cancer: ready for the clinic?
@nl
prefLabel
Chemoprevention of pancreatic cancer: ready for the clinic?
@ast
Chemoprevention of pancreatic cancer: ready for the clinic?
@en
Chemoprevention of pancreatic cancer: ready for the clinic?
@nl
P2860
P1476
Chemoprevention of pancreatic cancer: ready for the clinic?
@en
P2093
Craig D Logsdon
James L Abbruzzese
P2860
P304
P356
10.1158/1940-6207.CAPR-10-0216
P577
2010-11-01T00:00:00Z